DJIA 17,828.24 0.49 0.00%
NASDAQ 4,791.63 4.31 0.09%
S&P 500 2,067.56 -5.27 -0.25%
market minute promo

22.03 -0.20 (-0.90%)

Quote as of

company name or ticker

Recent Quotes

OMED $22.03 -0.90%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $22.25
Previous Close $22.23
Daily Range $22.01 - $22.50
52-Week Range $12.89 - $42.34
Market Cap $657.2M
P/E Ratio -39.70
Dividend (Yield) $0.00 (0.0%)
Volume 75,729
Average Daily Volume 143,776
Current FY EPS -$1.66





News & Commentary

5 Things Celgene Corporation's Management Wants You to Know

Following another strong quarterly earnings report, here are five things Celgene's management team would like investors to know.

OncoMed Pharma Offers Data from New Clinical, Biomarker Trial from Tarextumab, Demcizumab

Oncomed Offers Data from Phase 1a Trial of OMP-52M51 in Oral Plenary Session

Oncomed Pharmaceuticals' (OMED) CEO Paul Hastings on Q3 2014 Results - Earnings Call Transcript

Can Celgene Corporation Stock Motor to $150 Following Earnings?

After reporting another stellar quarter of estimate-topping profits, could this biotech behemoth gain another 50% and push its share price to $150 per share?

Is It Time To Consider OncoMed Pharmaceuticals Again?

OncoMed Pharmaceuticals (OMED) Jumps: Stock Up 5.4% - Tale of the Tape

4 Health Care Stocks Triggering Breakout Trades on Unusual Volume

3 Companies Investing In Stem Cell Research

These 7 States Have the Highest Rates of Pancreatic Cancer

Pancreatic cancer is arguably the most lethal form of the disease. Find out which seven states this disease occurs in most often, as well as what new pathways are being tested to treat this terrible disease.

See More OMED News...